Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 743-748

  Temmim, L ^a   Baker, H ^a   Sinowatz, F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; Kuwait; P53; Young patients

Indexed keywords

ESTROGEN; KI 67 ANTIGEN; PROGESTERONE; PROTEIN P53;

ADULT; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GRADING; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME 17P; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME;

ADULT; ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA; ESTROGENS; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; KUWAIT; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROGESTERONE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035060607     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. p53 mutations in human cancers
2. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers
3. p53 molecule as a prognostic marker in human malignancies
4. T antigen is bound to a host protein in SV40-transformed cells
5. Maintenance of p53 alterations throughout breast cancer progression
6. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
7. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells
8. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer
9. Angiogenesis as a biological and prognostic indicator in human breast cancer
10. The p53 tumor suppressor gene in breast cancer
11. p53 protein accumulation detected by five different antibodies. Relationship to prognosis and heat shock protein 70 in breast cancer
12. Clinical application of the p53 tumor suppressor gene
13. p53 onco-protein as a prognostic indicator in patients with breast cancer
14. Recent trends in U.S. breast cancer incidence, survival, and mortality rates
15. Histological grading and prognosis in breast cancer
16. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
17. Survival patterns among younger women with breast cancer. The effect of age, race, stage and treatment
18. Younger women with breast carcinoma have a poorer prognosis than older women
19. Age as a prognostic factor in breast cancer
20. Long-term outcome in women less than 30 years of age with breast cancer
21. The role of age in the course of breast cancer
22. Biological grading of breast cancer using antibodies to proliferating cells and other markers
23. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer, relationship between differentiation degree and axillary lymph node metastases
24. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlation with receptor status, proliferation markers, and clinical stage in human breast cancer
25. Prognostic relevance of p53 in node negative breast cancer
26. Expression of ras RB1 and p53 proteins in human breast cancer
27. p53 expression in breast cancer related to prognostic factors
28. Clonal p53 mutation in primary cervical cancer. Association with human papilloma-virus-negative tumors
29. Increased expression of mutant forms of p53 oncogene in primary lung cancer
30. Mutant p53 expression and DNA analysis in human breast cancer. Comparison with conventional clinicopathological parameters
31. Estrogen receptor protects p53 from deactivation by human double minute-2
32. Prognostic value of p53 for local failure in mastectomy-treated breast cnacer patients
33. p53 as an independent prognostic marker in lymph-node negative breast cancer patients
34. Association of p53 expression with tumor cell proliferation rates and clinical outcome in node-negative breast cancer
35. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
36. Abnormal p5 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up